Arvinas (ARVN) Receivables - Other (2017 - 2026)
Arvinas' (ARVN) quarterly Receivables - Other came in at $4.6 million in Q1 2026, down 42.5% year-on-year from $8.0 million in Q1 2025, and up 518.18% quarter-over-quarter from -$1.1 million in Q4 2025.
Arvinas (ARVN) Receivables - Other (2017 - 2026) Analysis & Trends
Arvinas' Receivables - Other history runs 10 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- On a quarterly basis, Receivables - Other fell 42.5% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 42.5% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, down 32.5% from the prior year.
- Receivables - Other climbed to $4.6 million in Q1 2026 per ARVN's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $10.6 million in Q2 2025 and bottomed at -$1.1 million in Q4 2025.
- The 5-year median for Receivables - Other is $5.8 million (2022), against an average of $5.3 million.
- Across the five-year window, Receivables - Other jumped 112.77% in 2024 and plunged 320.0% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $1.2 million in 2022, then soared by 100.0% to $2.4 million in 2023, then slumped by 79.17% to $500000.0 in 2024, then plunged by 320.0% to -$1.1 million in 2025, then soared by 518.18% to $4.6 million in 2026.
- Per Business Quant, the three latest ARVN Receivables - Other figures stand at $4.6 million (Q1 2026), -$1.1 million (Q4 2025), and $6.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.60 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 10.60 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 7.50 Mn |
| Sep 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Dec 31, 2023 | 2.40 Mn |